Search Results

3,094 Results for "%E2%80%9D%20target=".

Sort By

Press Releases

Amgen’s TEPEZZA®▼ (teprotumumab) Granted Marketing Authorisation as the First Targeted Treatment Specifically for Adults With Moderate-to-severe Thyroid Eye Disease (TED) in the United Kingdom

May 8, 2025
·
8 min read
Press Releases

Taiho Oncology Presents Data at the 2025 American Society of Clinical Oncology Annual Meeting

May 23, 2025
·
6 min read
Press Releases

BeiGene Presents Pioneering Cancer Research at ASCO 2025 – Redefining Treatment Across Hematology and Solid Tumors

May 22, 2025
·
19 min read
Press Releases

Omeros Corporation Announces Agreements to Acquire $80.5 Million of its Convertible Senior Notes Due 2026

May 12, 2025
·
6 min read
Press Releases

AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL cholesterol (LDL-C) reduction in PURSUIT Phase IIb trial

March 31, 2025
·
7 min read
Press Releases

80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - Evaxion presents striking EVX-01 data at the AACR Annual meeting

April 29, 2025
·
5 min read
Press Releases

XORTX Provides Update on FDA Type B Meeting Request

April 30, 2025
·
8 min read
Press Releases

Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b REZILIENT1 Trial of Zipalertinib at ASCO 2025

May 23, 2025
·
10 min read
Press Releases

[Ad hoc announcement pursuant to Art. 53 LR] Roche continues good momentum into 2025 with 6% (CER) sales growth in the first quarter

April 24, 2025
·
20 min read
Press Releases

4DMT Reports First Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones

May 9, 2025
·
10 min read